Nebula Genomics and Longenisis are taking a hard look at genomic data and health data with the help of blockchain.
The companies were recently featured in a Nature Medicine article titled “Experimenting with blockchain: Can one technology boost both data integrity and patients’ pocketbooks?” on the demonstration of their prototype.
The collaboration will be geared towards determining the true value of life data. In doing so, the groups will establish two new fields. The first is microdataeconomics, the study of the value of life data used for drug discovery like the structure and activity of specific molecules, both in vitro and in vivo. The second is macrodataeconomics, the study of the value of life data used to determine human health like electronic health records and genomics.
This new resource will help researchers by bringing huge amounts of data of many different types onto a single blockchain platform.